Particle.news

Netinho Died From Rare Plasmablastic B‑Cell Non‑Hodgkin Lymphoma

Doctors say the plasmablastic subtype is aggressive, harder to cure and spotlights limits in access to newer therapies in Brazil.

Overview

  • The singer Netinho died on Tuesday, Oct. 13, and Brazilian reports identify the cause as a plasmablastic B‑cell non‑Hodgkin lymphoma.
  • Plasmablastic lymphoma is an uncommon, fast‑growing B‑cell variant that is more frequent in people with weakened immune systems and has lower cure rates than many other non‑Hodgkin lymphomas.
  • Common warning signs include enlarged lymph nodes, unexplained fever, heavy night sweats, weight loss and lasting fatigue, and doctors say persistent symptoms should prompt clinical evaluation.
  • Definitive diagnosis requires a tissue biopsy plus imaging tests such as CT, MRI or PET‑CT and staging from I to IV to guide treatment choices.
  • Treatment options range from chemotherapy, radiotherapy and monoclonal antibodies to newer approaches such as bispecific antibodies and CAR‑T cell therapy, with CAR‑T not produced in Brazil and therefore harder for many patients to access; INCA estimates about 10,180 new non‑Hodgkin lymphoma cases in Brazil in 2026, underlining the public health relevance.